+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Aldehydes 52085-14-0
52085-14-0,MFCD01075698
Catalog No.:AA003K3A

52085-14-0 | 4-Benzyloxy-2-hydroxybenzaldehyde

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
97%
in stock  
$11.00   $8.00
- +
1g
98%
in stock  
$24.00   $17.00
- +
5g
97%
in stock  
$42.00   $29.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003K3A
Chemical Name:
4-Benzyloxy-2-hydroxybenzaldehyde
CAS Number:
52085-14-0
Molecular Formula:
C14H12O3
Molecular Weight:
228.2433
MDL Number:
MFCD01075698
SMILES:
O=Cc1ccc(cc1O)OCc1ccccc1
Properties
Properties
 
BP:
390.9°C at 760 mmHg  
Form:
Solid  
MP:
78-80°C  
Stability:
Air Sensitive  
Storage:
Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
236  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
4  
XLogP3:
3  

Upstream Synthesis Route

[1]JournaloftheChemicalSociety,1948,p.2254,2258

[1]BioorganicandMedicinalChemistry,2013,vol.21,#15,p.4502-4510

[2]Synlett,2011,#11,p.1605-1607

[3]OrganicProcessResearchandDevelopment,2011,vol.15,#5,p.1149-1162

[4]TetrahedronLetters,2013,vol.54,#31,p.4121-4124

[5]OrganicLetters,2008,vol.10,#21,p.5007-5010

[6]Patent:US2011/144195,2011,A1,.Locationinpatent:Page/Pagecolumn2;4;11

[7]Phosphorus,SulfurandSiliconandtheRelatedElements,2018,vol.193,#5,p.306-316

[8]Phosphorus,SulfurandSiliconandtheRelatedElements,2018,vol.193,#9,p.574-581

[9]JournalofMedicinalChemistry,2012,vol.55,#12,p.5797-5812

[10]BioorganicandMedicinalChemistryLetters,2014,vol.24,#15,p.3633-3637

[11]EuropeanJournalofMedicinalChemistry,2018,vol.143,p.1428-1435

[12]Patent:WO2015/200514,2015,A2,.Locationinpatent:Page/Pagecolumn69

[13]JournalofHeterocyclicChemistry,1987,vol.24,#1,p.75-77

[14]Patent:WO2013/119985,2013,A1,.Locationinpatent:Paragraph00335;00336

[15]Patent:WO2018/83171,2018,A1,.Locationinpatent:Page/Pagecolumn48;49

[16]JournaloftheAmericanChemicalSociety,2010,vol.132,#26,p.8828-8830

[17]Patent:WO2011/94560,2011,A1,.Locationinpatent:Page/Pagecolumn54

[18]Patent:US9075014,2015,B2,.Locationinpatent:Page/Pagecolumn39

[19]Patent:WO2012/11125,2012,A1,.Locationinpatent:Page/Pagecolumn145-146

[20]RikagakuKenkyushoIho,1940,vol.19,p.802,803

[21]Chem.Abstr.,1940,p.5842

[22]BioorganicandMedicinalChemistryLetters,1997,vol.7,#11,p.1421-1426

[23]Patent:US6610687,2003,B1,

[24]TetrahedronAsymmetry,2008,vol.19,#3,p.343-347

[25]BioorganicandMedicinalChemistryLetters,2008,vol.18,#19,p.5252-5254

[26]JournalofNaturalProducts,2009,vol.72,#11,p.2072-2075

[27]OrganicLetters,2012,vol.14,#17,p.4544-4547

[28]TetrahedronLetters,2015,vol.56,#11,p.1338-1343

[1]Heterocycles,2010,vol.81,#7,p.1697-1702

[2]JournaloftheAmericanChemicalSociety,2006,vol.128,#17,p.5887-5894

[3]BioorganicandMedicinalChemistryLetters,2010,vol.20,#22,p.6758-6763

[4]OrganicandBiomolecularChemistry,2017,vol.15,#44,p.9415-9423

[5]EuropeanJournalofMedicinalChemistry,2014,vol.86,p.257-269

[6]ArchivderPharmazie,2014,vol.347,#12,p.936-949

[7]BioorganicandMedicinalChemistry,2009,vol.17,#18,p.6567-6582

[8]EuropeanJournalofMedicinalChemistry,2012,vol.54,p.879-886

[9]Patent:CN104230845,2017,B,.Locationinpatent:Paragraph0437;0438;0439;0440

[10]JournalofOrganicChemistry,2007,vol.72,#26,p.10283-10286

[11]MedicinalChemistryResearch,2016,vol.25,#11,p.2485-2497

[12]Patent:CN104478836,2017,B,.Locationinpatent:Paragraph0054-0055

[13]Patent:EP1362844,2003,A1,.Locationinpatent:Page/Pagecolumn131-135

[14]JournalofMedicinalChemistry,2012,vol.55,#4,p.1538-1552

[15]SyntheticCommunications,1981,vol.11,#10,p.853-858

[16]HelveticaChimicaActa,1935,vol.18,p.816,826

[17]JournaloftheAmericanChemicalSociety,1961,vol.83,p.4787-4792

[18]Patent:US2003/153599,2003,A1,

[1]ActaChemicaScandinavica,SeriesB:OrganicChemistryandBiochemistry,1986,vol.40,#5,p.400-401

[2]ChemicalandPharmaceuticalBulletin,1998,vol.46,#2,p.222-230

[3]TetrahedronLetters,2012,vol.53,#40,p.5376-5379

[1]Patent:WO2007/92751,2007,A2,.Locationinpatent:Page/Pagecolumn33

Downstream Synthesis Route

[1]BioorganicandMedicinalChemistry,2013,vol.21,p.4502-4510

[2]Synlett,2011,p.1605-1607

[3]SyntheticCommunications,2020

[4]Organicprocessresearchanddevelopment,2011,vol.15,p.1149-1162

[5]TetrahedronLetters,2013,vol.54,p.4121-4124

[6]OrganicLetters,2008,vol.10,p.5007-5010

[7]Patent:US2011/144195,2011,A1.Locationinpatent:Page/Pagecolumn2;4;11

[8]Phosphorus,SulfurandSiliconandtheRelatedElements,2018,vol.193,p.306-316

[9]Phosphorus,SulfurandSiliconandtheRelatedElements,2018,vol.193,p.574-581

[10]JournalofMedicinalChemistry,2012,vol.55,p.5797-5812

[11]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.3633-3637

[12]Patent:WO2015/200514,2015,A2.Locationinpatent:Page/Pagecolumn69

[13]JournalofHeterocyclicChemistry,1987,vol.24,p.75-77

[14]Patent:WO2013/119985,2013,A1.Locationinpatent:Paragraph00335;00336

[15]Patent:WO2018/83171,2018,A1.Locationinpatent:Page/Pagecolumn48;49

[16]JournaloftheAmericanChemicalSociety,2010,vol.132,p.8828-8830

[17]Patent:WO2011/94560,2011,A1.Locationinpatent:Page/Pagecolumn54

[18]Patent:US9075014,2015,B2.Locationinpatent:Page/Pagecolumn39

[19]Patent:WO2012/11125,2012,A1.Locationinpatent:Page/Pagecolumn145-146

[20]RikagakuKenkyushoIho,1940,vol.19,p.802,803    Chem.Abstr.,1940,p.5842

[21]BioorganicandMedicinalChemistryLetters,1997,vol.7,p.1421-1426

[22]Patent:US6610687,2003,B1

[23]TetrahedronAsymmetry,2008,vol.19,p.343-347

[24]BioorganicandMedicinalChemistryLetters,2008,vol.18,p.5252-5254

[25]JournalofNaturalProducts,2009,vol.72,p.2072-2075

[26]OrganicLetters,2012,vol.14,p.4544-4547

[27]TetrahedronLetters,2015,vol.56,p.1338-1343

[1]Heterocycles,2010,vol.81,p.1697-1702

[2]JournaloftheAmericanChemicalSociety,2006,vol.128,p.5887-5894

[3]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.6758-6763

[4]OrganicandBiomolecularChemistry,2017,vol.15,p.9415-9423

[5]EuropeanJournalofMedicinalChemistry,2014,vol.86,p.257-269

[6]ArchivderPharmazie,2014,vol.347,p.936-949

[7]BioorganicandMedicinalChemistry,2009,vol.17,p.6567-6582

[8]EuropeanJournalofMedicinalChemistry,2012,vol.54,p.879-886

[9]Patent:CN104230845,2017,B.Locationinpatent:Paragraph0437;0438;0439;0440

[10]JournalofOrganicChemistry,2007,vol.72,p.10283-10286

[11]MedicinalChemistryResearch,2016,vol.25,p.2485-2497

[12]Patent:CN104478836,2017,B.Locationinpatent:Paragraph0054-0055

[13]Patent:EP1362844,2003,A1.Locationinpatent:Page/Pagecolumn131-135

[14]JournalofMedicinalChemistry,2012,vol.55,p.1538-1552

[15]SyntheticCommunications,1981,vol.11,p.853-858

[16]HelveticaChimicaActa,1935,vol.18,p.816,826

[17]JournaloftheAmericanChemicalSociety,1961,vol.83,p.4787-4792

[18]Patent:US2003/153599,2003,A1

[19]ChemicalandPharmaceuticalBulletin,2019,vol.67,p.351-360

[20]Patent:US2019/55226,2019,A1.Locationinpatent:Paragraph0405

[1]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.6758-6763

[2]Patent:WO2005/51938,2005,A1.Locationinpatent:Page/Pagecolumn131-132

[3]JournaloftheChemicalSociety,1948,p.2254,2258

[1]Patent:WO2018/83171,2018,A1.Locationinpatent:Page/Pagecolumn49

[2]BulletinoftheChemicalSocietyofJapan,1957,vol.30,p.3,6

[1]Patent:US2017/121315,2017,A1.Locationinpatent:Paragraph0474-0477

[2]JournaloftheChemicalSociety,1949,p.2058

[3]JournalofMedicinalChemistry,2019,vol.62,p.7400-7416

Literature

Title: N'-[(E)-4-Benz-yloxy-2-hy-droxy-benzyl-idene]-4-nitro-benzohydrazide monohydrate.

Journal: Acta crystallographica. Section E, Structure reports online 20120501

Title: (E)-2-(4-Benz-yloxy-2-hy-droxy-benzyl-idene)-N-phenyl-hydrazinecarbothio-amide.

Journal: Acta crystallographica. Section E, Structure reports online 20111201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 52085-14-0
124663-30-5

124663-30-5

 13246-46-3

13246-46-3

 144896-51-5

144896-51-5

 1486-51-7

1486-51-7

 29682-12-0

29682-12-0

 4397-53-9

4397-53-9
Building Blocks
More >
Tags:52085-14-0 Molecular Formula|52085-14-0 MDL|52085-14-0 SMILES|52085-14-0 4-Benzyloxy-2-hydroxybenzaldehyde